石药集团：石药创新上半年归母净亏损274.6万元

Group 1 - The company reported a revenue of 1.05 billion RMB for the six months ending June 30, 2025, representing a year-on-year growth of 7.99% [1] - The net loss attributable to shareholders was 2.746 million RMB, compared to a net profit of 137 million RMB in the same period last year [1] - The basic loss per share was 0.0020 RMB [1]